SCHEMBL623949

SCHEMBL623949

FC(F)(F)Oc1cccc(-c2cn3nc(N4CCC5(CCNCC5)CC4)sc3n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 6/20 0.47
F2RL3 Q96RI0 3/20 0.41
SCN9A Q15858 2/20 0.41
SCN4A P35499 1/20 0.41
THRB P10828 2/20 0.41
PIM3 Q86V86 2/20 0.40
MAPT P10636 3/20 0.40
TYRO3 Q06418 1/20 0.39
XDH P47989 1/20 0.38
FLT3 P36888 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL624740 0.95 PIM1 (0.48) PIM1F2RL3SCN9ASCN4ATHRB
SCHEMBL623207 0.95 PIM1 (0.48) PIM1F2RL3SCN9ASCN4ATHRB
SCHEMBL625255 0.87 PIM3 (0.48) PIM1F2RL3THRBPIM3MAPT
SCHEMBL625249 0.84 PIM2 (0.48) PIM1F2RL3SCN9ASCN4ATHRB
SCHEMBL625512 0.84 THRB (0.44) PIM1F2RL3THRBMAPTRXFP1
SCHEMBL623948 0.84 DYRK1A (0.47) PIM1PIM3
SCHEMBL625561 0.82 PIM1 (0.49) PIM1F2RL3PIM3TYRO3XDH
SCHEMBL623867 0.81 PIM1 (0.44) PIM1F2RL3THRBMAPTXDH
SCHEMBL623996 0.80 THRB (0.42) PIM1F2RL3THRBMAPTHCRTR1
SCHEMBL623206 0.79 PIM1 (0.47) PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020217-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed